The program aims to accelerate the development of 6 Indian innovations to improve ease of access to diagnostics and treatment monitoring
These digital initiatives are expected to enhance the accessibility and efficiency of drug safety monitoring and standards compliance
PLI scheme envisages manufacturing of 41 Bulk Drugs with a total outlay of Rs. 6,940 cr. during the tenure of the scheme from 2020-21 to 2029-30
Pfizer INDovation program partners with NIPER Ahmedabad to incubate healthcare startups
Subscribe To Our Newsletter & Stay Updated
